Ophthalmology Management

Home
United States
Tampa, FL
Ophthalmology Management

Call Directions Website

Practical insights and real world strategies to help ophthalmologists run more efficient, successful practices.

11/04/2026

🌍 Johnson & Johnson announces a major commitment to expanding global eye care access!

Building on partnerships that have already reached nearly 60 million children and helped restore sight to more than 70,000 cataract patients, the company is taking further steps to improve access to essential vision care worldwide.

👓 What's next for the initiative?

🔗 Read more: https://ow.ly/jCcM5103IWj

11/02/2026

👁️ When an IOL becomes dislocated, what's the best surgical approach?

There's no one-size-fits-all solution.

At , Ajay Kuriyan, MD, led an instruction course exploring secondary IOL placement techniques, from anterior chamber lenses to iris and scleral fixation.

🎥 Discover the key surgical considerations, practical tips and importance of patient selection when choosing the right approach.

▶️ Watch now: https://ow.ly/X8kL50ZZZwN

10/30/2026

👁️ Are you giving cataract patients too many choices, or helping them make the right one?

Effective patient education goes beyond explaining IOL technology. It's about building trust, understanding lifestyle needs and setting realistic expectations.

In Ophthalmology Management, Brian Szabo, DO, shares four strategies for helping patients navigate premium IOL decisions while supporting long-term practice success.

🔗 Read more: https://ow.ly/OfYp50ZZYK4

10/29/2026

JOIN US!
Free webinar on EMERGING TRENDS IN GLAUCOMA

Led by Christine Funke, MD, this program will explore current and future treatment approaches—from time-tested topical medications to breakthrough sustained-release options, and more commonly used surgical techniques.

Wednesday, Nov 4 8 p.m. ET

Click here to register: https://thea.broadcastmed.io/live/10/page/40

Sponsored by Théa

10/29/2026

👁️ FDA approves Lucamzi, a biosimilar to Lucentis.

Supported by a phase 3 study involving 582 patients with wet AMD, the approval introduces another ranibizumab treatment option, with a US launch planned for 2027.

🔗 Read more: https://ow.ly/COLf5101ZtL

10/28/2026

43% of patients are open to using a healthcare credit card for vision care, yet only 7% actually do.

According to the CareCredit VisionIQ Study, this nearly 6x financing gap represents an opportunity for eyecare practices to improve access to recommended treatments while supporting practice revenue.

Discover how proactive financing conversations can help bridge the gap between patient interest and action.

Learn more: https://ophthalmologymanagement.com/issues/2026/october/the-patient-financing-gap-that-could-cost-you/

by Care Credit

https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://ophthalmologymanagement.com/media/dydjvcpi/adobestock_526526544.jpg

10/27/2026

👁️ Interested in CAIRS but unsure where to start?

At , corneal surgeon Soosan Jacob, MS, FRCS, DNB, MNAMS, led an instruction course designed to help surgeons confidently transition to corneal allogeneic intrastromal ring segments (CAIRS) for keratoconus.

🎥 From patient selection and surgical planning to tissue preparation and technique customization, discover the practical guidance shared during the course.

▶️ Watch now: https://ow.ly/xmNT50ZZYmC

10/23/2026

💰 Are your patients truly informed about what they're paying for?

Fee transparency in ophthalmology goes beyond simply providing a price.

From cataract surgery upgrades to insurance coverage and out-of-pocket costs, clear communication is essential for building patient trust.

In Ophthalmology Management, Priya M. Mathews, MD, MPH, and Kevin J. Corcoran, COE, FNAO, explore how practices can balance transparent pricing, patient understanding and financial sustainability.

🔗 Read more: https://ow.ly/YrH750ZYquP

10/22/2026

👁️ Could genetics help shape the future of dry eye treatment?

At , Oculis CEO Riad Sherif, MD, discusses the Phase 3 PREDICT-1 trial of investigational licaminlimab, a TNF-α inhibitor being developed for dry eye disease.

With a genotype-based approach to patient selection, the trial aims to explore more targeted treatment options, with topline results expected by year-end.

🎥 Watch the interview: https://ow.ly/HhS450ZZYin

Address

400 N. Ashley Drive , Ste 2600
Tampa, FL
33602

Telephone

+12674925200

Website

http://www.ophthalmologymanagement.com/

Alerts

Be the first to know and let us send you an email when Ophthalmology Management posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.